• Boehringer Ingelheim offers MyStudyWindow to provide patients, families, caregivers, and doctorsconsistent access to information about Boehringer Ingelheim’s actively recruiting studies conducted atglobal site locations
• The platform features patient-centric study titles and descriptions, educational content, and guidance onthe clinical trial selection and enrollment process
• Anonymous condition-based questionnaires identify and pre-screen potentially relevant studies based on afew questions about patient diagnosis, disease stage, and treatment history

Click here to download/view the press release